2019
DOI: 10.14336/ad.2018.0501
|View full text |Cite
|
Sign up to set email alerts
|

Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury

Abstract: Aging may aggravate the damage and dysfunction of different components of multiorgan and thus increasing multiorgan ischemia/reperfusion (IR) injury. IR injury occurs in many organs and tissues, which is a major cause of morbidity and mortality worldwide. The kinase mammalian target of rapamycin (mTOR), an atypical serine/threonine protein kinase, involves in the pathophysiological process of IR injury. In this review, we first briefly introduce the molecular features of mTOR, the association between mTOR and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(21 citation statements)
references
References 176 publications
0
20
0
1
Order By: Relevance
“…AMPK is a serine-threonine kinase that functions as a key metabolic regulator for mitochondrial activity and cardiomyocyte energy homeostasis [36, 37]. Activated AMPK by Thr 172 site phosphorylation exerts myocardial protection against various cardiac diseases, including ischemia reperfusion injury, infarction, and DOX-cardiotoxicity [4, 38, 39]. DOX application could markedly inhibit the AMPK activity in cardiomyocytes [38].…”
Section: Discussionmentioning
confidence: 99%
“…AMPK is a serine-threonine kinase that functions as a key metabolic regulator for mitochondrial activity and cardiomyocyte energy homeostasis [36, 37]. Activated AMPK by Thr 172 site phosphorylation exerts myocardial protection against various cardiac diseases, including ischemia reperfusion injury, infarction, and DOX-cardiotoxicity [4, 38, 39]. DOX application could markedly inhibit the AMPK activity in cardiomyocytes [38].…”
Section: Discussionmentioning
confidence: 99%
“…The mTOR pathway plays an essential role in pathophysiology of ischemic injury [27]. mTOR is a negative regulator of autophagy, e.g.…”
Section: Ogd and Rapamycin Inhibit Mtor Signaling Pathwaymentioning
confidence: 99%
“…activation of mTOR resulted in decreased autophagic flux [28]. The expressions of phosphorylated forms of S6K and 4EBP1 are indicators of mTOR activity [27].…”
Section: Ogd and Rapamycin Inhibit Mtor Signaling Pathwaymentioning
confidence: 99%
“…As a result, it is imperative to seek effective therapeutic approaches by studies on the pathogenesis of PD, including modulation of neuronal-vascular pathways, neuroinflammation, and neuronal autophagy, etc. (Rangel-Barajas et al, 2015 ; Zou et al, 2017 ; Weng et al, 2018 ; Zhang et al, 2018 ; Liu et al, 2019 ; Tian et al, 2019 ). For example, Cystatin C (CYS C) participates in neurovascular units activity by interacting with the vascular endothelial growth factors (VEGFs) and autophagy pathways.…”
Section: Discussionmentioning
confidence: 99%